![]() | Up a level |
Hermine, Olivier ORCID: 0000-0003-2574-3874, Hoster, Eva
ORCID: 0000-0002-0749-1389, Walewski, Jan
ORCID: 0000-0003-4247-2674, Bosly, Andre, Stilgenbauer, Stephan, Thieblemont, Catherine
ORCID: 0000-0002-9941-2448, Szymczyk, Michal, Bouabdallah, Reda, Kneba, Michael, Hallek, Michael, Salles, Gilles
ORCID: 0000-0002-9541-8666, Feugier, Pierre, Ribrag, Vincent, Birkmann, Josef, Forstpointner, Roswitha, Haioun, Corinne, Haenel, Mathias, Casasnovas, Rene Olivier, Finke, Juergen, Peter, Norma, Bouabdallah, Kamal, Sebban, Catherine, Fischer, Thomas, Duehrsen, Ulrich, Metzner, Bernd, Maschmeyer, Georg, Kanz, Lothar, Schmidt, Christian, Delarue, Richard, Brousse, Nicole, Klapper, Wolfram, Macintyre, Elizabeth, Delfau-Larue, Marie-Helene, Pott, Christiane, Hiddemann, Wolfgang, Unterhalt, Michael and Dreyling, Martin
(2016).
Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL Younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network.
Lancet, 388 (10044).
S. 565 - 576.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1474-547X
Hermine, Olivier, Hoster, Eva, Walewski, Jan, Ribrag, Vincent, Brousse, Nicole, Thieblemont, Catherine ORCID: 0000-0002-9941-2448, Bouabdallah, Reda, Dohner, Hartrnut, Feugier, Pierre, Forspointner, Roswitha, Haioun, Corinne, Kneba, Michael, Haenel, Mathias, Casasnovas, Olivier, Mertelsmann, Roland H., Hallek, Michael, Bosly, Andre, Nowacki, M., Klapper, Wolfram, Gisselbrecht, Christian, Coiffier, Bertrand, Unterhalt, Michael, Hiddemann, Wolfgang and Dreyling, Martin H.
(2012).
Alternating Courses of 3x CHOP and 3x DHAP Plus Rituximab Followed by a High Dose ARA-C Containing Myeloablative Regimen and Autologous Stem Cell Transplantation (ASCT) Increases Overall Survival When Compared to 6 Courses of CHOP Plus Rituximab Followed by Myeloablative Radiochemotherapy and ASCT in Mantle Cell Lymphoma: Final Analysis of the MCL Younger Trial of the European Mantle Cell Lymphoma Network (MCL net).
Blood, 120 (21).
WASHINGTON:
AMER SOC HEMATOLOGY.
ISSN 0006-4971
Hoster, Eva ORCID: 0000-0002-0749-1389, Klapper, Wolfram, Hermine, Olivier
ORCID: 0000-0003-2574-3874, Kluin-Nelemans, Hanneke C., Walewski, Jan
ORCID: 0000-0003-4247-2674, van Hoof, Achiel, Trneny, Marek
ORCID: 0000-0002-6952-6073, Geisler, Christian H., Di Raimondo, Francesco, Szymczyk, Michal, Stilgenbauer, Stephan, Thieblemont, Catherine
ORCID: 0000-0002-9941-2448, Hallek, Michael, Forstpointner, Roswitha, Pott, Christiane, Ribrag, Vincent, Doorduijn, Jeanette, Hiddemann, Wolfgang, Dreyling, Martin H. and Unterhalt, Michael
(2014).
Confirmation of the Mantle-Cell Lymphoma International Prognostic Index in Randomized Trials of the European Mantle-Cell Lymphoma Network.
J. Clin. Oncol., 32 (13).
S. 1338 - 1347.
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
Sureda, Anna, Andre, Marc, Borchmann, Peter, da Silva, Maria G., Gisselbrecht, Christian, Vassilakopoulos, Theodoros P., Zinzani, Pier Luigi and Walewski, Jan (2020). Improving outcomes after autologous transplantation in relapsed/refractory Hodgkin lymphoma: a European expert perspective. BMC Cancer, 20 (1). LONDON: BMC. ISSN 1471-2407
Walewski, Jan ORCID: 0000-0003-4247-2674, Hellmann, Andrzej, Siritanaratkul, Noppadol, Ozsan, Guner Hayri, Ozcan, Muhit, Chuncharunee, Suporn, Goh, Ai Sim, Jurczak, Wojciech
ORCID: 0000-0003-1879-8084, Koren, Jan, Paszkiewicz-Kozik, Ewa, Wang, Bingxia, Singh, Shalini, Huebner, Dirk, Engert, Andreas and von Tresckow, Bastian
(2018).
Prospective study of brentuximab vedotin in relapsed/refractory Hodgkin lymphoma patients who are not suitable for stem cell transplant or multi-agent chemotherapy.
Br. J. Haematol., 183 (3).
S. 400 - 411.
HOBOKEN:
WILEY.
ISSN 1365-2141